1. Market Research
  2. > Pharmaceutical
  3. > Pathology Market Trends
  4. > Pathology Analysis & Statistics, January 2016 (p50)

Pathology Analysis & Statistics, January 2016 (p50)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

All regions

1471-1500 of about 9 200 reports

Purchase Reports From Reputable Market Research Publishers

North America Clinical nutrition Market Segmented By type of applications, by Ingredients, by type of services, by route of administration, and by Geography Growth, Trends And

North America Clinical nutrition Market Segmented By type of applications, by Ingredients, by type of services, by route of administration, and by Geography Growth, Trends And

  • $ 3 850
  • Industry report
  • January 2016
  • by Mordor Intelligence LLP

The North America market for Clinical nutrition, estimated at US$1075 billion in 2015, is further projected to reach US$ 12.30 billion by 2020 with a CAGR of 2.38%. The clinical nutrition market has grown ...

  • Industries : Pathology
  • Countries : North America
Middle East & Africa  Kidney Cancer Therapeutics & Diagnostics Market - Segmented by type of cancer and geography (2015-2020)

Middle East & Africa Kidney Cancer Therapeutics & Diagnostics Market - Segmented by type of cancer and geography (2015-2020)

  • $ 3 850
  • Industry report
  • January 2016
  • by Mordor Intelligence LLP

The frequency of kidney cancer, worldwide, has increased in the recent years. Changes in lifestyle, excessive smoking, increased consumption of alcohol and a rise in obesity because of sedentary life routines ...

  • Industries : Pathology
  • Countries : Africa
Global Bladder Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and geography (2015-2020)

Global Bladder Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer and geography (2015-2020)

  • $ 4 250
  • Industry report
  • January 2016
  • by Mordor Intelligence LLP

Bladder cancer is a urologic malignancy arising from the epithelial lining of the urinary bladder. It is the ninth most common cancer worldwide in men and women, with the highest recurrence rate. Though ...

  • Industries : Pathology
  • Countries : World
North America Liver Cancer Market - Segmented by type, technology, end-user and geography (2015 - 2020)

North America Liver Cancer Market - Segmented by type, technology, end-user and geography (2015 - 2020)

  • $ 3 850
  • Industry report
  • January 2016
  • by Mordor Intelligence LLP

Mordor Intelligence analysts forecasted the North America Liver Cancer Market to grow at a CAGR of 7-17% over the period, 2015-2020. The market is currently valued at USD 283 million, as per 2015. North ...

  • Industries : Pathology
  • Countries : North America
Asia-Pacific  Uterine cancer therapeutics & Diagnostics Market - Segmented by type of cancer and geography (2015-2020)

Asia-Pacific Uterine cancer therapeutics & Diagnostics Market - Segmented by type of cancer and geography (2015-2020)

  • $ 3 850
  • Industry report
  • January 2016
  • by Mordor Intelligence LLP

Uterine cancer is a common form of cancer of the female reproductive system that initiates in the lining of the uterus. According to the American Cancer Society, around 47,130 new cases of endometrial ...

  • Industries : Pathology
  • Countries : Asia
Europe Clinical nutrition Market Segmented By type of applications, by Ingredients, by type of services, by route of administration, and by Geography Growth, Trends And Forecas

Europe Clinical nutrition Market Segmented By type of applications, by Ingredients, by type of services, by route of administration, and by Geography Growth, Trends And Forecas

  • $ 3 850
  • Industry report
  • January 2016
  • by Mordor Intelligence LLP

Europe market for Clinical nutrition, estimated at US$9.23 billion in 2015, is further projected to reach US$13.85 billion by 2020 with a CAGR of 8.46%. Clinical nutrition foods are specifically formulated, ...

  • Industries : Pathology
  • Countries : Europe
Latin America Kidney Cancer Therapeutics & Diagnostics Market - Segmented by type of cancer and geography (2015-2020)

Latin America Kidney Cancer Therapeutics & Diagnostics Market - Segmented by type of cancer and geography (2015-2020)

  • $ 3 850
  • Industry report
  • January 2016
  • by Mordor Intelligence LLP

The frequency of kidney cancer, worldwide, has increased in the recent years. Changes in lifestyle, excessive smoking, increased consumption of alcohol and a rise in obesity because of sedentary life routines ...

  • Industries : Pathology
North America Bladder cancer Therapeutics & Diagnostics Market- Segmented by type of cancer and geography (2015-2020)

North America Bladder cancer Therapeutics & Diagnostics Market- Segmented by type of cancer and geography (2015-2020)

  • $ 3 850
  • Industry report
  • January 2016
  • by Mordor Intelligence LLP

Bladder cancer is a urologic malignancy arising from the epithelial lining of the urinary bladder. It is the ninth most common cancer worldwide in men and women, with the highest recurrence rate. Though ...

  • Industries : Pathology
  • Countries : North America
Middle East CT Market - Growth, Trends And Forecasts (2015 - 2020)

Middle East CT Market - Growth, Trends And Forecasts (2015 - 2020)

  • $ 3 850
  • Industry report
  • January 2016
  • by Mordor Intelligence LLP

The Middle East & Africa CT Scanners market is poised to reach $XX billion by the end of 2020 growing at a CAGR of XX%.Computed tomography (CT) is an imaging process that customs special x-ray equipment ...

  • Industries : Pathology, General Medicine and Specialty Medicine
  • Countries : Africa
Asia Pacific CT Market - Growth, Trends And Forecasts (2015 - 2020)

Asia Pacific CT Market - Growth, Trends And Forecasts (2015 - 2020)

  • $ 3 850
  • Industry report
  • January 2016
  • by Mordor Intelligence LLP

The Asia Pacific CT Scanners market has been estimated to be valued at USD XX billion and it is projected to reach $XX billion by the end of 2020 at a CAGR of XX% during the forecast period 2015 to 2020. ...

  • Industries : Pathology, General Medicine and Specialty Medicine
  • Countries : Asia
Quetiapine  - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

Quetiapine - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

  • $ 653
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug, Pathology
Quetiapine  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Quetiapine - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug, Pathology
Fluoxetine  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Fluoxetine - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Pathology
Fluoxetine  - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

Fluoxetine - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

  • $ 653
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Pathology
Cancer Bundle

Cancer Bundle

  • $ 24 225
  • Industry report
  • January 2016
  • by TriMark Publications

The Cancer Reports Bundle includes the following TriMark Publications reports at a 15% discount off the individual reports being purchased separately: - Biomarker Technology Platforms for Cance ...

  • Industries : Pathology, Biopharmaceutical, General Medicine and Specialty Medicine, Pharmaceutical, Drug and Medication
  • Countries : United States
Flomoxef  - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Flomoxef - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

  • $ 1 523
  • Industry report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Pathology
Quetiapine  - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Quetiapine - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

  • $ 1 523
  • Industry report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Pathology
Vasculitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Vasculitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Vasculitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III ...

  • Industries : Pathology
  • Countries : World, Europe, India, China
Pertussis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Pertussis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Pertussis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III ...

  • Industries : Pathology
  • Countries : World, Europe, India, China
Pulmonary Embolism-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Pulmonary Embolism-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Pulmonary Embolism-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

  • Industries : Pathology
  • Countries : World, Europe, India, China
Spasticity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Spasticity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Spasticity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III ...

  • Industries : General Medicine and Specialty Medicine, Pathology
  • Countries : World, Europe, India, China
Anaplastic Lymphoma Kinase (ALK) Inhibitors -Pipeline Insights, 2016

Anaplastic Lymphoma Kinase (ALK) Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Anaplastic Lymphoma Kinase (ALK) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the ...

  • Industries : General Medicine and Specialty Medicine, Pathology
 Thalassemia-Pipeline Insights, 2016

Thalassemia-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Thalassemia-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Thalassemia. The DelveInsight’sReport ...

  • Industries : Pathology
 Ventricular Arrhythmia-Pipeline Insights, 2016

Ventricular Arrhythmia-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Ventricular Arrhythmia-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Ventricular Arrhythmia. ...

  • Industries : Pathology
Allergic Conjunctivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Allergic Conjunctivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Allergic Conjunctivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

  • Industries : Pathology
  • Countries : World, Europe, India, China
Chancroid-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Chancroid-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Chancroid-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III ...

  • Industries : Pathology
  • Countries : World, Europe, India, China
Urinary Incontinence-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Urinary Incontinence-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Urinary Incontinence-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

  • Industries : Pathology
  • Countries : World, Europe, India, China
Amebic Liver Abscess-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Amebic Liver Abscess-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Amebic Liver Abscess-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

  • Industries : Pathology
  • Countries : World, Europe, India, China
Ocular Hypertension-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Ocular Hypertension-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Ocular Hypertension-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

  • Industries : Pathology
  • Countries : World, Europe, India, China
Pharyngitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Pharyngitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Pharyngitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III ...

  • Industries : Pathology
  • Countries : World, Europe, India, China

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.